STATCenter·
STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
Read at STAT →
Health · 1 sources covering this
STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/be9d696209aa4db33f3c64f247582589d9d0c305" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated"></iframe>
